ROGER BROWN: Open Payments
NPI 1538269683 · MANDEVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$43,400 in 189 payments from 14 companies in 2025. Trend: 2023 $46,504 · 2024 $39,910 · 2025 $43,400
Honoraria: $20,050Speaker / faculty: $15,300Travel & lodging: $4,221Food & beverage: $3,829
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 52 | $24,533 |
| ABBVIE INC. | 30 | $16,660 |
| Noven Therapeutics, LLC | 24 | $397 |
| Axsome Therapeutics, Inc. | 18 | $389 |
| Collegium Pharmaceutical, Inc. | 16 | $335 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $244 |
| Corium, LLC | 11 | $220 |
| Otsuka America Pharmaceutical, Inc. | 4 | $186 |
| Tris Pharma Inc | 7 | $139 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $136 |
Products named: Qelbree, VRAYLAR, Xelstrym, Auvelity, Jornay PM, CAPLYTA, Azstarys, REXULTI.
Industry payments across LA — which companies pay providers there.
